PHYSICIANS MAY EARN PAY BOOST OF UP TO 5.1 PERCENT FROM MIPPA UPDATE PLUS E-PRESCRIBING AND PQRI INCENTIVES
Read Full Article »

Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
Read Full Article »

Chemokine Protein CXCR3 Receptor Found in Celiac Disease
Read Full Article »

Incentives to e-Prescribe
Read Full Article »

Silent Stroke Affects 10 Percent of Healthy Middle-Aged Patients
Read Full Article »

Siemens Healthcare Solutions DCA 2000+ Analyzer

Conjunctivitis Test

PRODUCT DIRECTORY

Home --> Diagnostics --> CLIA-Waived Rapid Testing --> Conjunctivitis test -->

CLIA-Waived Rapid Testing

Check All \| Uncheck All
		RPS Adenovirus Detector The FDA cleared and CLIA waived RPS Adeno Detector is the first true point of care test available for conjunctivitis. It provides a definitive result in 10 minutes and essentially makes available an accurate laboratory confirmation of adenoviral conjunctivitis at the time of the exam. The RPS Adeno Detector� can aid health care providers to make an accurate diagnosis, foster patient acceptance of more supportive therapies, identify contagious viral conjunctivitis, and limit spread of disease while simultaneously reducing ocular antibiotic resistance and the cost of unnecessary antibiotics....

Check All \| Uncheck All

CONJUNCTIVITIS TEST

The conjunctivitis test is medical equipment that provides rapid, point-of-service analysis to confirm a diagnosis of conjunctivitis or inflammation of the conjunctiva of the eye. This is a highly contagious condition. The rapid results provided by the conjunctivitis test provides physicians with key information for diagnostic and treatment decisions in medical offices and clinics.

<< Go To Top >>